Literature DB >> 12861436

Nandrolone treatment decreases the level of rat kidney alpha(1B)-adrenoceptors.

Staffan Uhlén1, Jonas Lindblom, Anna Kindlundh, Paul Mugisha, Fred Nyberg.   

Abstract

Abuse of anabolic androgenic steroids (AAS) is associated with serious side effects, such as hypertension and fluid retention. Renal alpha(1)- and alpha(2)-adrenoceptors are implicated in the regulation of blood pressure and fluid balance. In the present study, the levels of renal alpha(1A)-, alpha(1B)-, alpha(2A)- and alpha(2B)-adrenoceptors, and spleen alpha(1B)-adrenoceptors, were quantified in tissue membranes from rats treated with the AAS nandrolone decanoate (15 mg/kg) for 14 days. The radioligands used were [(3)H]-prazosin and [(3)H]-RX821002. The nandrolone treatment caused a 50% reduction of kidney alpha(1B)-adrenoceptors (from 15 fmol/mg protein in control rats to 6.5 fmol/mg protein in treated rats). In contrast, the levels of kidney alpha(1A)-, alpha(2A)- and alpha(2B)-, and spleen alpha(1B)-adrenoceptors were unaffected. These results raise the possibility that a decreased level of kidney alpha(1B)-adrenoceptors may cause some of the effects observed on blood pressure and fluid balance in heavy abuse of AAS.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12861436     DOI: 10.1007/s00210-003-0763-y

Source DB:  PubMed          Journal:  Naunyn Schmiedebergs Arch Pharmacol        ISSN: 0028-1298            Impact factor:   3.000


  41 in total

1.  Renal alpha 2a/d-adrenoceptor subtype function: Wistar as compared to spontaneously hypertensive rats.

Authors:  H D Intengan; D D Smyth
Journal:  Br J Pharmacol       Date:  1997-07       Impact factor: 8.739

2.  Testosterone dependence of salt-induced hypertension in Sabra rats and role of renal alpha(2)-adrenoceptor subtypes.

Authors:  Mostafa Khalid; Norelyaquine Ilhami; Yves Giudicelli; Jean-Pierre Dausse
Journal:  J Pharmacol Exp Ther       Date:  2002-01       Impact factor: 4.030

3.  A modification of the Lowry procedure to simplify protein determination in membrane and lipoprotein samples.

Authors:  M A Markwell; S M Haas; L L Bieber; N E Tolbert
Journal:  Anal Biochem       Date:  1978-06-15       Impact factor: 3.365

4.  The anabolic-androgenic steroid nandrolone decanoate affects the density of dopamine receptors in the male rat brain.

Authors:  A M Kindlundh; J Lindblom; L Bergström; J E Wikberg; F Nyberg
Journal:  Eur J Neurosci       Date:  2001-01       Impact factor: 3.386

5.  Increased dopaminergic and 5-hydroxytryptaminergic activities in male rat brain following long-term treatment with anabolic androgenic steroids.

Authors:  I Thiblin; A Finn; S B Ross; C Stenfors
Journal:  Br J Pharmacol       Date:  1999-03       Impact factor: 8.739

6.  Isolation and characterization of the gene encoding the rat alpha 1B adrenergic receptor.

Authors:  B Gao; G Kunos
Journal:  Gene       Date:  1993-09-15       Impact factor: 3.688

7.  Alpha1-adrenoceptor subtypes on rat afferent arterioles assessed by radioligand binding and RT-PCR.

Authors:  M Salomonsson; M Oker; S Kim; H Zhang; J E Faber; W J Arendshorst
Journal:  Am J Physiol Renal Physiol       Date:  2001-07

Review 8.  Selective DNA binding by the androgen receptor as a mechanism for hormone-specific gene regulation.

Authors:  F Claessens; G Verrijdt; E Schoenmakers; A Haelens; B Peeters; G Verhoeven; W Rombauts
Journal:  J Steroid Biochem Mol Biol       Date:  2001 Jan-Mar       Impact factor: 4.292

9.  Kidneys and primary hypertension--initiators, stabilizers or/and victim-aggravators?

Authors:  B Folkow
Journal:  Blood Press       Date:  1994-07       Impact factor: 2.835

10.  Testosterone regulation of renal alpha 2B-adrenergic receptor mRNA levels.

Authors:  G Gong; M L Johnson; W A Pettinger
Journal:  Hypertension       Date:  1995-03       Impact factor: 10.190

View more
  2 in total

Review 1.  Role of α- and β-adrenergic signaling in phenotypic targeting: significance in benign and malignant urologic disease.

Authors:  M Archer; N Dogra; Z Dovey; T Ganta; H-S Jang; J A Khusid; A Lantz; M Mihalopoulos; J A Stockert; A Zahalka; L Björnebo; S Gaglani; M R Noh; S A Kaplan; R Mehrazin; K K Badani; P Wiklund; K Tsao; D J Lundon; N Mohamed; F Lucien; B Padanilam; M Gupta; A K Tewari; N Kyprianou
Journal:  Cell Commun Signal       Date:  2021-07-20       Impact factor: 5.712

2.  Nandrolone Decanoate: Use, Abuse and Side Effects.

Authors:  Federico Giuseppe Patanè; Aldo Liberto; Andreana Nicoletta Maria Maglitto; Pasquale Malandrino; Massimiliano Esposito; Francesco Amico; Giuseppe Cocimano; Giuseppe Li Rosi; Dario Condorelli; Nunzio Di Nunno; Angelo Montana
Journal:  Medicina (Kaunas)       Date:  2020-11-11       Impact factor: 2.430

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.